Beloit College Alum🥎, Go blue 〽️, currently a postdoctoral fellow at Dana Farber Cancer Institute 🧬🦠, crocheted a blanket of the periodic table for fun🧶
Today, the @US_FDA granted accelerated approval to the RAF inhibitor tovorafenib for patients 6 months and older with relapsed or refractory pediatric low-grade glioma with certain BRAF alterations. Learn more: https://t.co/e1dhCjmoe4
Congratulations to the first class of Damon Runyon-@StJudeResearch Pediatric Cancer Fellows! These exceptional early-career scientists are working to accelerate progress and develop cures for some of the most difficult-to-treat cancers affecting children: https://t.co/Pn5ghAsDWO